Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein

Targeting apoptotic cell-death pathways has been a subject of growing interest in discovery of novel anti-cancer agents. Bcl-2 is a member of Bcl-2 family protein that is crucial for cell survival by supressing apoptosis and its overexpression is frequently detected in many type of cancers. Inactiv...

Full description

Bibliographic Details
Main Authors: Afriza, Dhona, Ichwan, Solachuddin J. A., Suriyah, Wastuti Hidayati, Wahyuni, Fatma Suri, ., Yanwirasti, Tejo, Bimo Ario
Format: Article
Language:English
English
Published: Ectodermal Dysplasia Group Turkey 2018
Subjects:
Online Access:http://irep.iium.edu.my/69230/
http://irep.iium.edu.my/69230/
http://irep.iium.edu.my/69230/1/69230_Prediction%20on%20Binding%20Affinity%20of%20Nordentatin.pdf
http://irep.iium.edu.my/69230/2/69230_Prediction%20on%20Binding%20Affinity%20of%20Nordentatin_SCOPUS.pdf
id iium-69230
recordtype eprints
spelling iium-692302019-01-16T08:18:47Z http://irep.iium.edu.my/69230/ Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein Afriza, Dhona Ichwan, Solachuddin J. A. Suriyah, Wastuti Hidayati Wahyuni, Fatma Suri ., Yanwirasti Tejo, Bimo Ario R Medicine (General) RS Pharmacy and materia medica Targeting apoptotic cell-death pathways has been a subject of growing interest in discovery of novel anti-cancer agents. Bcl-2 is a member of Bcl-2 family protein that is crucial for cell survival by supressing apoptosis and its overexpression is frequently detected in many type of cancers. Inactivation of Bcl-2 has been considered as an ideal strategy in anti-cancer therapies. A large number of bioactive compounds derived from natural source including Nordentatin and Quercetin have been reported to possess anticancer activities. Here we report the binding affinities of Nordentatin and Quercetin in silico against anti-apoptotic Bcl-2 protein using molecular docking programs. We demonstrate for the first time that Nordentatin showed optimum binding affinity with Bcl-2, similar to those shown by Quercetin. As the Quercetin has been previously known to play a role in cancer cell apoptosis through down-regulation of Bcl-2, the result indicated that Nordentatin could also be proposed as a prospective anticancer molecule via inhibition of Bcl-2 protein. Ectodermal Dysplasia Group Turkey 2018 Article PeerReviewed application/pdf en http://irep.iium.edu.my/69230/1/69230_Prediction%20on%20Binding%20Affinity%20of%20Nordentatin.pdf application/pdf en http://irep.iium.edu.my/69230/2/69230_Prediction%20on%20Binding%20Affinity%20of%20Nordentatin_SCOPUS.pdf Afriza, Dhona and Ichwan, Solachuddin J. A. and Suriyah, Wastuti Hidayati and Wahyuni, Fatma Suri and ., Yanwirasti and Tejo, Bimo Ario (2018) Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein. Journal of International Dental and Medical Research, 11 (3). pp. 1116-1122. E-ISSN 1309-100X http://www.jidmr.com/journal/wp-content/uploads/2019/01/64_M18_654_Solachuddin_J_A_Ichwan.pdf
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
English
topic R Medicine (General)
RS Pharmacy and materia medica
spellingShingle R Medicine (General)
RS Pharmacy and materia medica
Afriza, Dhona
Ichwan, Solachuddin J. A.
Suriyah, Wastuti Hidayati
Wahyuni, Fatma Suri
., Yanwirasti
Tejo, Bimo Ario
Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein
description Targeting apoptotic cell-death pathways has been a subject of growing interest in discovery of novel anti-cancer agents. Bcl-2 is a member of Bcl-2 family protein that is crucial for cell survival by supressing apoptosis and its overexpression is frequently detected in many type of cancers. Inactivation of Bcl-2 has been considered as an ideal strategy in anti-cancer therapies. A large number of bioactive compounds derived from natural source including Nordentatin and Quercetin have been reported to possess anticancer activities. Here we report the binding affinities of Nordentatin and Quercetin in silico against anti-apoptotic Bcl-2 protein using molecular docking programs. We demonstrate for the first time that Nordentatin showed optimum binding affinity with Bcl-2, similar to those shown by Quercetin. As the Quercetin has been previously known to play a role in cancer cell apoptosis through down-regulation of Bcl-2, the result indicated that Nordentatin could also be proposed as a prospective anticancer molecule via inhibition of Bcl-2 protein.
format Article
author Afriza, Dhona
Ichwan, Solachuddin J. A.
Suriyah, Wastuti Hidayati
Wahyuni, Fatma Suri
., Yanwirasti
Tejo, Bimo Ario
author_facet Afriza, Dhona
Ichwan, Solachuddin J. A.
Suriyah, Wastuti Hidayati
Wahyuni, Fatma Suri
., Yanwirasti
Tejo, Bimo Ario
author_sort Afriza, Dhona
title Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein
title_short Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein
title_full Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein
title_fullStr Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein
title_full_unstemmed Prediction on binding affinity of nordentatin and quercetin against anti-apoptotic BCL-2 protein
title_sort prediction on binding affinity of nordentatin and quercetin against anti-apoptotic bcl-2 protein
publisher Ectodermal Dysplasia Group Turkey
publishDate 2018
url http://irep.iium.edu.my/69230/
http://irep.iium.edu.my/69230/
http://irep.iium.edu.my/69230/1/69230_Prediction%20on%20Binding%20Affinity%20of%20Nordentatin.pdf
http://irep.iium.edu.my/69230/2/69230_Prediction%20on%20Binding%20Affinity%20of%20Nordentatin_SCOPUS.pdf
first_indexed 2023-09-18T21:38:16Z
last_indexed 2023-09-18T21:38:16Z
_version_ 1777412966943031296